Finance

Lists
Q1 2027 earnings • released • EPS beat +7.52% • Revenue miss -4.06%
See results
ALIVUS:NSE
Alivus Life Sciences Ltd
₹1,158.00
+5.69%
(+62.30) 1D
Jul 31, 3:30:00 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for ALIVUS...
Open
₹1,135.50
High
₹1,177.60
Low
₹1,108.00
Mkt. cap
142.13B
Avg. vol.
104.14K
Volume
237.29K
P/E ratio
25.23
52-wk high
₹1,193.90
52-wk low
₹819.00
EPS
₹45.90
No. of employees
2K
Open
₹1,135.50
High
₹1,177.60
Low
₹1,108.00
Mkt. cap
142.13B
Avg. vol.
104.14K
Volume
237.29K
P/E ratio
25.23
52-wk high
₹1,193.90
52-wk low
₹819.00
EPS
₹45.90
No. of employees
2K
News stories
From sources across the web
About Alivus Life Sciences Ltd
CEOYasir Rawjee
Employees2.2K
Founded2001
Headquarters-
SectorPharmaceutical industry
Websitealivus.com
Last report
Jul 31, 2026
Fiscal period
Q1 2027
EPS / Est. (INR)
₹13.01 / ₹12.10
+7.52%beat
Revenue / Est. (INR)
6.40B / 6.68B
-4.06%miss
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
5.88B
6.73B
6.89B
6.40B
Cost of goods sold
2.49B
2.76B
2.71B
-
Cost of revenue
2.49B
2.76B
2.71B
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
664.00M
663.70M
781.22M
-
Operating expense
1.78B
1.85B
2.24B
-
Total operating expenses
4.27B
4.61B
4.95B
-
Operating income
1.61B
2.12B
1.94B
-
Other non operating income
147.20M
139.28M
227.78M
-
EBT including unusual items
1.74B
1.98B
2.16B
-
EBT excluding unusual items
1.74B
2.24B
2.16B
-
Income tax expense
441.11M
481.31M
531.38M
-
Effective tax rate
25.33%
24.26%
24.62%
-
Other operating expenses
934.91M
988.28M
1.26B
-
Net income
1.30B
1.50B
1.63B
-
Net profit margin
22.11%
22.33%
23.60%
-
Earnings per share
10.58
13.80
13.22
13.01
Interest and investment income
-
-
-
-
Interest expense
-13.18M
-14.94M
-13.09M
-
Net interest expenses
-13.18M
-14.94M
-13.09M
-
Depreciation and amortization charges
184.35M
196.58M
202.00M
-
EBITDA
1.78B
2.25B
2.13B
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps